DNMT1 and acute myeloid leukemia: Furthermore, the alteration of CSRP1 mRNA levels is observed upon treatment with a DNMT1 inhibitor for THP1 cells.<h4>Conclusion</h4>The CSRP1 has potential as a novel prognostic factor and appears to influence the immune response in acute myeloid leukemia.